Empowering independent endocrinologists to shape the future of diabetes care.
Valendo Health partners with endocrinology practices to help grow their businesses, improve care for patients with diabetes, and shape the future of diabetes care through value-based care contracts. Valendo implements virtual care visits and remote patient monitoring, centralizes and streamlines practice operations and develops and manages value-based care contracts.
Dave Terry is CEO and Co-Founder of Valendo Health, a company that provides endocrinology practices with the resources to efficiently and profitably deliver superior clinical outcomes and comprehensive diabetes patient care through an innovative tech platform. Dave is the founder of three value-based care businesses, and a thought leader in the areas of healthcare delivery, payment reform, and value-based performance. Throughout his 20+ year career he has worked as an advisor, senior executive and entrepreneur with a focus on helping hundreds of providers all along the care continuum prepare for and succeed within risk arrangements. At Archway Health he built and led a team of clinicians, data scientists, actuaries and technologists focused on building longitudinal data sets designed to understand what High Quality Value Based (HQVB) care looks like, identify who is delivering it, and to create delivery and financing models that help improve the delivery of healthcare across markets.
He previously held leadership roles at Chartis Group, Harborside Healthcare and Partners Healthcare (now MGB). Dave holds an MBA from Harvard Business School and a BA in Political Science from Columbia University.